Possibilities of correcting oxidative stress in multiple sclerosis

Drugs that alter the course of multiple sclerosis have long become part of the practice of treating this serious disease. In the last decade, their mechanism of action is being actively studied. One of the interesting aspects of the pathogenesis of multiple sclerosis is oxidative stress, in relation to which these drugs can have a corrective effect. The authors cite their own data, which made it possible to establish that, against the background of treatment with Glatiramer acetate, there is an increase in the activity of the antioxidant system, which has an indirect membrane-stabilizing effect. This pathogenetic mechanism partially explains the favorable clinical effect of the drug.